Clinical Trials Browser

OTHER × Adrenal Cortex Neoplasms × Clear all

NCT06006013 2026-02-18

Cabozantinib in Combination With Pembrolizumab for the Treatment of Patients With Locally Advanced, Metastatic, or Unresectable Adrenal Cortical Cancer

Phase 2 Recruiting

21 enrolled

Endocrine

Adrenal Cortex Neoplasms, Adrenocortical Carcinoma

NCT00700414 2025-12-18

International Pediatric Adrenocortical Tumor Registry

Recruiting

9,999 enrolled

Adrenal Cortex Neoplasms

NCT04897321 2025-10-24

B7-H3-Specific Chimeric Antigen Receptor Autologous T-Cell Therapy for Pediatric Patients With Solid Tumors (3CAR)

Phase 1 Recruiting

32 enrolled

CNSDermatologicGastrointestinalGenitourinarySarcoma

Adrenal Cortex Neoplasms, Carcinoma, Melanoma, Neoplasms, Germ Cell and Embryonal, Wilms Tumor, Neuroblastoma, Rhabdomyosarcoma, Sarcoma, Sarcoma, Ewing, Osteosarcoma, Hepatoblastoma, Sarcoma, Clear Cell, Neurofibrosarcoma, Rhabdoid Tumor, Desmoplastic Small Round Cell Tumor

NCT07072143 2025-07-18

PARTNER

Recruiting

6,250 enrolled

CNSDermatologicGastrointestinalHead & NeckOther solid neoplasmSarcomaThoracic

Pleuropulmonary blastoma, Nasopharyngeal Carcinoma, Adrenal Cortex Neoplasms, Melanoma, Mesothelioma, Pancreatic Neoplasms, Thymus Neoplasms, Thyroid Neoplasms, Esthesioneuroblastoma, Olfactory, Gastrointestinal Stromal Tumors

NCT03370718 2024-12-10

Cabozantinib in Treating Patients With Locally Advanced or Metastatic Unresectable Adrenocortical Carcinoma

Phase 2 Completed

18 enrolled 5 charts

Adrenal Cortex Neoplasms

NCT03612232 2024-08-19

CaboACC

Phase 2 Unknown

37 enrolled

Endocrine

Adrenal Cortex Neoplasms, Adrenal Gland Neoplasms, Adrenocortical Carcinoma

NCT06050057 2023-09-22

Surgical Treatment of Adrenal Diseases- Laparoscopic vs. Robotic-assisted Adrenalectomy

Recruiting

100 enrolled

Endocrine

Adrenal Cortex Diseases, Adrenal Cortex Neoplasms, Adrenal Gland Diseases, Adrenal Gland Neoplasms, Adrenal Hyperplasia, Congenital, Cushing Syndrome, Pheochromocytoma, Adrenocortical Adenoma, Adrenocortical Carcinoma

NCT04890444 2022-02-14

CASE

Recruiting

2,000 enrolled

Endocrine

Adrenal incidentaloma, ACTH Syndrome, Ectopic, Adrenal Cortex Neoplasms, Adrenal Insufficiency, Adrenal Hyperplasia, Congenital, Cushing Syndrome, Hyperaldosteronism, Pheochromocytoma

NCT04666220 2021-02-12

VETC, Prognostic and Predictive Value in Renal Cell Carcinoma and Adrenal Carcinoma

Unknown

180 enrolled

Genitourinary

Adrenal Cortex Neoplasms, Carcinoma, Renal Cell

NCT02720484 2019-05-01

Nivolumab in Treating Patients With Metastatic Adrenocortical Cancer

Phase 2 Terminated

10 enrolled 11 charts

Adrenal Cortex Neoplasms

NCT00215202 2018-05-17

Phase II Trial of ZD1839 (Iressa) in Patients With Nonresectable Adrenocortical Carcinoma (ACC)

Phase 2 Completed

16 enrolled

Endocrine

Adrenal Cortex Neoplasms, Adrenal Gland Neoplasms

NCT02831179 2017-09-28

Veliparib, Capecitabine, and Temozolomide in Patients With Advanced, Metastatic, and Recurrent Neuroendocrine Tumor

Phase 1 Withdrawn

DermatologicEndocrineGastrointestinalNET

Non functioning pancreatic endocrine tumor, Adrenal Cortex Neoplasms, Carcinoid Tumor, Vipoma, Glucagonoma, Insulinoma, Pheochromocytoma, Somatostatinoma, Zollinger-Ellison Syndrome, Carcinoma, Merkel Cell, Carcinoma, Medullary, Neuroendocrine Tumors, Multiple Endocrine Neoplasia Type 1, Multiple Endocrine Neoplasia Type 2a, Multiple Endocrine Neoplasia Type 2b

NCT00768365 2008-10-08

adrenal

Completed

105 enrolled

Adrenal incidentaloma, Adrenal Cortex Neoplasms